Antimicrobial focused assessment of core drug use indicators using WHO/INRUD methodology in post-operative patients at tertiary care Hospital in Rohtak, India

Authors

  • Dr. Vikas Pt. BD Sharma Post Graduate Institute of Medical Sciences( PGIMS) Rohtak, Haryana, India
  • Dr. Rakesh Mittal Professor, Department of Pharmacology, PGIMS, Rohtak
  • Dr. MC Gupta Senior Professor and Head, department of Pharmacology, PGIMS Rohtak
  • Dr. Sanjay Marwah Senior Professor and Unit Head, Department of General Surgery, PGIMS Rohtak

Keywords:

Drug utilization research, WHO, Essential medicine

Abstract

Drug utilization research (DUR) provides the important community data with regards to the pattern of drug use prevalent in the society, identify irrational prescription, indicate overuse, underuse of drugs and their cost effectiveness. A number of indicators have been developed, standardized and evaluated by the World Health Organization (WHO) to evaluate rational use of drugs. These indicators are grouped into three categories namely: prescribing indicators, patient care indicators and facility indicators. The study was aimed to evaluate rational drug use based on WHO-core drug use indicators in tertiary care hospital in post-operative patients. Average number of drugs per prescription was 5.99, Percentage of drugs prescribed by generic name were 50%, Percentage of encounters in which an antibiotic was prescribed was 100%, Percentage of encounters with an injectable were 92.45%, Percentage of drugs prescribed from WHO Essential Medicine List were (EML) 54%. These indicator of antimicrobials per prescription met the WHO optimal use recommendations but prescription of generic drugs and prescription from essential medicine list were found to be lower than the WHO recommendations. Use of Generic medicines and drugs from essential medicine list should be promoted. Government and hospitals should workup to enhance rational use of drugs.

Downloads

Download data is not yet available.

Downloads

Published

2021-08-30

Issue

Vol. 11 No. 8 (2021): Aug

Section

Research Articles

License

Copyright (c) 2021 International Journal of Pharmacological Research

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
    4. Author must Submit Copyright form  After acceptance of Article

How to Cite

1.
Dr. Vikas, Mittal R, Gupta M, Marwah S. Antimicrobial focused assessment of core drug use indicators using WHO/INRUD methodology in post-operative patients at tertiary care Hospital in Rohtak, India. Int J of Pharmc Res [Internet]. 2021 Aug. 30 [cited 2025 Mar. 14];11(8):e5644. Available from: https://ssjournals.co.in/index.php/ijpr/article/view/5644